000 01539 a2200433 4500
005 20250516002008.0
264 0 _c20110325
008 201103s 0 0 eng d
022 _a1473-5571
024 7 _a10.1097/QAD.0b013e32833f147f
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartin, Allison
245 0 0 _aAbacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial.
_h[electronic resource]
260 _bAIDS (London, England)
_cNov 2010
300 _a2657-63 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCardiovascular Diseases
_xchemically induced
650 0 4 _aDideoxynucleosides
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xphysiology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aReverse Transcriptase Inhibitors
_xadverse effects
650 0 4 _aViral Load
700 1 _aAmin, Janaki
700 1 _aCooper, David A
700 1 _aCarr, Andrew
700 1 _aKelleher, Anthony D
700 1 _aBloch, Mark
700 1 _aBaker, David
700 1 _aWoolley, Ian
700 1 _aEmery, Sean
773 0 _tAIDS (London, England)
_gvol. 24
_gno. 17
_gp. 2657-63
856 4 0 _uhttps://doi.org/10.1097/QAD.0b013e32833f147f
_zAvailable from publisher's website
999 _c20159441
_d20159441